Table 1.
Characteristics of study subjects
| Participant category (n) | Median age (yr [IQR]) | Gendera | Ethnicity and no. of subjectsb | Median duration of HIV-1 diagnosis (yr [IQR]) | Median CD4+ T cell count (cells/mm3 [IQR]) | Median HIV-1 viral load (copies/ml [IQR]) | |
|---|---|---|---|---|---|---|---|
| M | F | ||||||
| Controller (30) | 46.5 (40.5-52) | 23 | 7 | C, 13; L, 4; A, 1; AA, 10; NA, 2 | 13 (6-18) | 794 (569-1,059) | 50 (40-302) |
| HAART-suppressed (20) | 48 (39.5-51) | 17 | 3 | C, 11; L, 5; A, 1; AA, 3 | 13 (9.8-17) | 686 (568-1,069) | 75 (50-75) |
| Virologic noncontroller (18) | 49.5 (38.5-54) | 15 | 3 | C, 9; A, 1; AA, 8 | 14 (8.5-20) | 523 (370.5-744.5) | 37,568 (17,573-69,763) |
| Immunologic progressors (20) | 43 (37-47) | 17 | 3 | C, 10; L, 5; A, 1; AA, 3; NA, 1 | 8 (5-16) | 200 (144.5-231.5) | 150,974 (89,532-230,970) |
| HIV-1 negative (22)c | 49 (44-54.5) | 12 | 8 | C, 8; L, 2; A, 3 | |||
a
F, female; M, male.
b
C, Caucasian; L, Latino/Hispanic; A, Asian; AA, African-American; NA, Native American.
c
Some information about the gender and ethnicity of the HIV-1-negative group was not available.